Zanco, Julia

Citations 2

Estimated VESALIUS-Like Eligibility and Projected Cardiovascular Benefit in US Adults

European Heart Journal - Quality of Care and Clinical Outcomes | August 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ehjqcco/qcag130 | PMID 42624502

Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease

JAMA Oncology | February 19, 2026 | Volume: 12 | Issue: 4 | Pages: 419

10.1001/jamaoncol.2025.6605 | PMID 41712203

This cohort study examines the association of bruton tyrosine kinase inhibitor therapy in B-cell malignant disease with increased risk of pericardial effusion and cardiovascular outcomes.